Dengue Infection Is Three Times More Common Than Previously Estimated

Global levels of dengue infection are more than three times higher than previous estimates from the World Health Organization, according to new research just published in the journal Nature.

20130408-035829.jpg

The new research has resulted in the creation of “the first detailed and up-to-date map of dengue distribution worldwide.” This has allowed researchers to “estimate the total numbers of people affected by the virus globally, regionally and nationally. The findings will help to guide efforts in vaccine, drug and vector control strategies.”

Dengue, alternately known as ‘breakbone fever’, is a sometimes fatal viral infection that is transmitted to humans via mosquitoes. In the coming years, as a result of rising temperatures and increasing levels of precipitation, mosquitos are predicted to greatly expand upon their current range. And with them, the many diseases that they carry, such as malaria and dengue.

“There are currently no licensed vaccines or specific treatments for dengue, and substantial efforts to control the mosquitoes that transmit the disease have not stopped its rapid emergence and global spread. Until now, little was known about the current distribution of the risk of dengue virus infection and its public health burden around the world.”


Dr Samir Bhatt, who led the modelling for the study, says: “Our aim was to take all of the evidence that is currently available on the distribution of dengue worldwide and combine it with the latest in mapping and mathematical modelling to produce the most refined risk maps and burden estimates. We then hope to use this knowledge to help predict the future burden of the disease.”

The new research has revealed that “dengue is ubiquitous throughout the tropics, with local spatial variations in risk influenced strongly by rainfall, temperature and urbanisation. The team estimate that there are 390 million dengue infections across the globe each year, of which 96 million reach any level of clinical or subclinical severity. This is more than triple the WHO’s most recent estimates of 50-100 million infections per year.”

Professor Simon Hay elaborates: “We found that climate and population spread were important factors for predicting the current risk of dengue around the world. With globalisation and the constant march of urbanisation, we anticipate that there could be dramatic shifts in the distribution of the disease in the future: the virus may be introduced to areas that previously were not at risk, and those that are currently affected may experience increases in the number of infections.

“We hope that the research will initiate a wider discussion about the significant global impact of this disease.”

“Of the 96 million apparent infections, Asia bore 70 per cent of the burden. India alone accounted for around one-third of all infections. The results indicate that with 16 million infections, Africa’s burden is almost equivalent to that of the Americas and is significantly larger than previously appreciated. The authors suggest that the hidden African dengue burden could be a result of the disease being masked by symptomatically similar illnesses, under-reporting and highly variable treatment-seeking behaviour.”

Professor Jeremy Farrar, Director of the Wellcome Trust Vietnam Research Programme and Oxford University Clinical Research Unit Hospital for Tropical Diseases in Vietnam, explains that the map and estimates produced by Hay’s group set the benchmark for the disease: “This is the first systematic robust estimate of the extent of dengue. The evidence that we’ve gathered here will help to maximise the value and cost-effectiveness of public health and clinical efforts, by indicating where limited resources can be targeted for maximum possible impact

With the ubiquitous nature of the disease in Asia and the Americas, the recent and “unexpected” outbreaks in Southern Europe, and the growing presence in Africa, what happens next could be very important. Professor Farrar states: “This really does represent a crucial period in the global spread of dengue.”

Jimmy Whitworth, Head of International Activities at the Wellcome Trust, said: “Over time, this comprehensive map of global disease burden will also help to demonstrate which control measures are making the biggest difference in reducing the number of people suffering from dengue infection. Without a vaccine or specific treatment options, it’s crucial that we understand where best to direct the limited resources available for preventing this resurgent disease.”

Image Credit: Commons

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top